Chlamydia Pneumoniae Igg/Igm
Catalog No. | SCPNGMW |
---|---|
Specimen | WB/S/P |
Dimensions | Height: 60mm, Length: 300mm, Height: 84mm, Length: 300mm |
Intended Use
The Mycoplasma Pneumoniae IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG and IgM antibody to Chlamydia pneumoniae in human serum, plasma or whole blood. It is intended to be used as a screening test and as an aid in the diagnosis of infection with L. interrogans.
Product Description
SUMMARY
Chlamydia pneumoniae (C. pneumoniae) is a common species of bacteria and a major cause of pneumonia around the world. Approximately 50% of adults have evidence of past infection by age 20, and reinfection later in life is common. Many studies have suggested a direct association between C. pneumoniae infection and other inflammatory diseases such as atherosclerosis, acute exacerbations of COPD, and asthma.Diagnosis of C. pneumoniae infection is challenging due to the fastidious nature of the pathogen, the considerable seroprevalence, and the possibility of transient asymptomatic carriage. Established diagnostic laboratory methods include isolation of the organism in the cell culture, serological assays and PCR. Microimmunofluorescence test (MIF), is the current “gold standard” for serological diagnosis, but the assay still lacks standardization and is technically challenging. Antibody immunoassays are the most common serology tests used and primary chlamydial infection is characterized by a predominant IgM response within 2 to 4 weeks and a delayed IgG and IgA response within 6 to 8 weeks. However, in reinfection, IgG and IgA levels rise quickly, often in 1-2 weeks whereas IgM levels may rarely be detected. For this reason, IgA antibodies have shown to be a reliable immunological marker of primary, chronic and recurrent infections especially when combined with the detection of IgM.
PRINCIPLE
Chlamydia pneumoniae IgG/IgM Rapid Test kit is based on the principle of a qualitative immunochromatographic assay for the determination of Chlamydia pneumoniae IgG/IgM antibody in the in human serum, plasma or whole blood.
StripA consists of: 1) a burgundy colored conjugate pad containing C. pneumoniae antigen conjugated with colloid gold (C. pneumoniae Antigen conjugates), 2) a nitrocellulose membrane strip containing a test band (T band) and a control band (C band). The T band is pre-coated with mouse anti-human IgG antibody, and the C band is pre-coated with goat anti-mouse IgG antibody.
Strip B consists of : 1) a burgundy colored conjugate pad containing C. pneumoniae antigen conjugated with colloid gold (C. pneumoniae Antigen conjugates), 2) a nitrocellulose membrane strip containing a test band (T band) and a control band (C band). The T band is pre-coated with mouse anti-human IgM antibody, and the C band is pre-coated with goat anti-mouse IgG antibody.